Financial Consulate’s AbbVie ABBV Stock Holding History

Financial Consulate’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$667K	Buy	3,069 +61	+2%	+$13.5K	0.08%	68
2025 Q4	$687K	Sell	3,008 -151	-5%	-$34.4K	0.09%	68
2025 Q3	$731K	Buy	+3,159	New	+$643K	0.1%	67
2023 Q2	–	Sell	-2,514	Closed	-$401K	–	42
2023 Q1	$401K	Buy	2,514 +35	+1%	+$5.35K	0.14%	85
2022 Q4	$401K	Sell	2,479 -999	-29%	-$153K	0.14%	90
2022 Q3	$467K	Buy	3,478 +2	+0.1%	+$287	0.2%	59
2022 Q2	$532K	Buy	3,476 +1	+0%	+$153	0.25%	53
2022 Q1	$563K	Buy	3,475 +181	+5%	+$26.3K	0.22%	60
2021 Q4	$446K	Buy	3,294 +1	+0%	+$118	0.15%	82
2021 Q3	$355K	Buy	3,293 +1,002	+44%	+$114K	0.13%	87
2021 Q2	$258K	Buy	2,291 +26	+1%	+$2.93K	0.09%	106
2021 Q1	$245K	Buy	2,265 +2	+0.1%	+$214	0.1%	98
2020 Q4	$243K	Buy	+2,263	New	+$217K	0.1%	93

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Consulate's ABBV Position: Q1 2026 in Review

Financial Consulate increased its AbbVie (ABBV) stake by 2% in Q1 2026, buying an estimated $13.5K and bringing the position to 3,069 shares worth $667K. The position accounts for 0.08% of the portfolio, ranked #68.

Financial Consulate first reported a position in ABBV in Q4 2020 and has held it in 13 quarters since. The position peaked at $731K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Financial Consulate held 3,069 shares of AbbVie worth $667K as of Q1 2026.
Financial Consulate bought 61 AbbVie shares in Q1 2026, an estimated $13.5K.
AbbVie made up 0.08% of Financial Consulate's portfolio in Q1 2026, its #68 holding.
Financial Consulate first reported a position in AbbVie in Q4 2020 and has held it in 13 quarters since.
Financial Consulate's AbbVie position peaked at $731K in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.